JIPMER has achieved a major milestone by upgrading its resource hub to a Centre of Excellence for Health Technology Assessment (HTA), set to lead India's evidence-based healthcare decisions.

  • JIPMER's Resource Hub has been officially upgraded to a Centre of Excellence for HTA.
  • The hub has already completed 30 research studies and 40 capacity-building activities.
  • The Centre will lead the development of national HTA standards and methodological guidelines.

The Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) has reached a significant milestone in the medical landscape. Its dedicated Resource Hub for Health Technology Assessment has been officially upgraded to a Centre of Excellence for Health Technology Assessment (HTA). This transition marks a pivotal shift in how medical technologies and interventions are evaluated within the Indian healthcare ecosystem.

As of 2026, the hub has demonstrated exceptional research capabilities. The institute reported that it has successfully completed 30 comprehensive research studies and contributed to or organized 40 national and international capacity-building initiatives. Furthermore, the center's academic rigor is reflected in its publication record, with 31 peer-reviewed articles appearing in prestigious national and international medical journals.

Read Also:World Health Organization Issues Warning Over Global Rise in Dementia Cases

Why This Matters

BozokMedia analysis shows that as healthcare costs rise globally, the ability to scientifically assess the value of new medical technologies becomes critical. By establishing this Centre of Excellence, JIPMER is positioning itself to provide the clinical and economic evidence required to guide government spending and clinical protocols, ensuring that only the most effective technologies reach the patient.

The evolution of JIPMER into an HTA Centre of Excellence will bridge the gap between clinical innovation and sustainable healthcare policy.

In its expanded capacity, JIPMER will take on a leadership role in strengthening HTA methodologies across the country. This includes providing technical guidance on advanced assessment methods and contributing to the creation of updated national HTA standards and best practices. The Centre will also act as a watchdog for quality assurance in HTA studies conducted nationwide.

Beyond policy, the Centre will engage in specialized methodological research and multicentric studies. These efforts are designed to generate high-quality evidence that supports informed decision-making for healthcare providers and policymakers alike. Additionally, JIPMER will remain a cornerstone for capacity building, training the next generation of health economists and medical researchers.

Did You Know?: Health Technology Assessment (HTA) is a multidisciplinary process that evaluates the clinical, economic, and social impact of medical interventions.

Frequently Asked Questions

1. What is the primary goal of the JIPMER HTA Centre?
The goal is to provide scientific evidence to help healthcare decision-makers choose the most effective and cost-efficient medical technologies.

2. How will this benefit the general public?
It ensures that public and private healthcare resources are spent on treatments and technologies that are proven to work, improving overall patient outcomes.